Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-05
1993-06-01
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, A61K 31365, C07D30930
Patent
active
052160157
ABSTRACT:
This invention relates to compounds which are steroidyl derivatives of 4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one and the corresponding ring-opened hydroxy acid form thereof which are useful as antihypercholesterolemic agents, to pharmaceutical compositions including such compounds, and to their use in treating hypercholesterolemia.
REFERENCES:
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4661483 (1987-04-01), Hoffman et al.
patent: 4857546 (1989-08-01), Duggan et al.
patent: 4863957 (0589-09-01), Neuenschwande et al.
patent: 4892884 (1990-01-01), Neuenschwande et al.
patent: 4900754 (1990-02-01), Regan et al.
patent: 4904691 (1990-02-01), Neuenschwande et al.
patent: 4904692 (1990-02-01), Regan et al.
patent: 4939143 (1990-07-01), Regan et al.
Proc. Natl. Acad. Sci. USA vol. 81, pp. 6861-6865, Nov. 1984, Schroepfer et al., 5alpha-Cholest-8(14)-en-3.beta.-o1-15-one lowers serum cholesterol and induces profound changes in the levels.
J. Biol. Chem., vol. 252, No. 24, Dec. 25, pp. 8975-8980, 1977, Schroepfer et al., Inhibition of Sterol Biosynthesis in L Cells and Mouse Liver Cells by 15-Oxygenated Sterols.
J. Biol. Chem., vol. 240, No. 22, Nov. 25, pp. 7306-14, 1974, Brown et al., Suppression of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity and Inhibition of.
J. Biol. Chem., vol. 248, No. 24, Dec. 25, pp. 8408-17, 1973, Kandutsch et al., Inhibition of Sterol Synthesis in Cultured Mouse Cells by 7alpha-Hydroxycholesterol, 7.beta.-Hydroxycholesterol, and.
J. Biol. Chem., vol. 249, No. 19, Oct. 10, pp. 6057-61, 1974, Kandutsch et al., Inhibition of Sterol Synthesis in Cultured Mouse Cells by Cholesterol Derivatives Oxygenated in the Side Chain.
Jpn. Kokai Tokkyo Koho JP 01 68,367 [89 68,367], Wakatsuka et al., Bicyclic esters or lactones and analogs as MMG-CoA reductase inhibitors, their preparation, and formulations.
J. Biol. Chem., vol. 257, No. 4,1929-1936, 1982, Pinkerton et al., 14alpha-Ethyl-5alpha-cholest-7-ene-3.beta.,15alpha-diol, a Potent Inhibitor of Sterol Biosynthesis, Has Two Sites of.
J. Biol., Chem., vol. 251, No. 6, 1745-1758 (1976), Bell et al., Inhibition of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Hepatoma Tissue.
Chang Michael N.
McGarry Daniel G.
Regan John R.
Volz Francis A.
Darkes Paul R.
Ivy C. Warren
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
Trinh Ba K.
LandOfFree
Compounds having hypocholesterolemic properties does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having hypocholesterolemic properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having hypocholesterolemic properties will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814860